Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Heska Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016

Heska Corporation
Posted on: 19 Oct 16

PR Newswire

LOVELAND, Colo., Oct. 19, 2016

LOVELAND, Colo., Oct. 19, 2016 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostics and products, plans to announce its third quarter 2016 financial results in a press release to be issued on Tuesday, November 1, 2016 before the market opens. The Company plans to host a conference call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day, Tuesday, November 1, 2016.

To access the conference call:

  • From within the United States, please dial 1-888-599-8667
  • From outside of the United States, please dial 1-913-312-1502
  • Reference Conference ID: 9382912

The conference call will be webcast live from the Company's website on www.heska.com.

A telephonic replay of the conference call will be available beginning two hours after the end of the call and continue through 11:59 p.m. ET on Tuesday, November 8, 2016.

To access the replay:

  • From within the United States, please dial 1-844-512-2921
  • From outside the United States, please dial 1-412-317-6671
  • Reference Replay Pin Number: 9382912

The webcast will also be archived on www.heska.com until December 31, 2016.

About Heska

Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostics and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software, and single use offerings such as in-clinic heartworm diagnostic tests, heartworm preventives, allergy immunotherapy and allergy testing. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space.  For further information on Heska and its products, visit the company's website at www.heska.com.

At Heska Corporation:

At Hayden IR:

John McMahon, Chief Financial Officer          

Brett Maas, Managing Partner

970.619.3082

646.536.7331


brett@haydenir.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heska-schedules-third-quarter-2016-earnings-release-and-conference-call-for-november-1-2016-300347335.html

SOURCE Heska Corporation

PR Newswire
www.prnewswire.com

Last updated on: 19/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.